Annual Non Current Assets
$15.50 K
-$96.80 K-86.20%
December 31, 2023
Summary
- As of February 12, 2025, CNTX annual long term assets is $15.50 thousand, with the most recent change of -$96.80 thousand (-86.20%) on December 31, 2023.
- During the last 3 years, CNTX annual non current assets has fallen by -$152.50 thousand (-90.77%).
- CNTX annual non current assets is now -90.77% below its all-time high of $168.00 thousand, reached on December 31, 2020.
Performance
CNTX Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Non Current Assets
$259.00 K
+$248.60 K+2390.38%
September 1, 2024
Summary
- As of February 12, 2025, CNTX quarterly long term assets is $259.00 thousand, with the most recent change of +$248.60 thousand (+2390.38%) on September 1, 2024.
- Over the past year, CNTX quarterly non current assets has increased by +$248.60 thousand (+2390.38%).
- CNTX quarterly non current assets is now -85.78% below its all-time high of $1.82 million, reached on September 30, 2021.
Performance
CNTX Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Non Current Assets Formula
Non Current Assets = Property, Plant, and Equipment + Intangible Assets + Long-Term Investments + Deferred Tax Assets + Other Non-Current Assets
CNTX Non Current Assets Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -86.2% | +2390.4% |
| 3 y3 years | -90.8% | +391.5% |
| 5 y5 years | -54.3% | +391.5% |
CNTX Non Current Assets Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -86.2% | at low | at high | +2390.4% |
| 5 y | 5-year | -90.8% | at low | -85.8% | +2390.4% |
| alltime | all time | -90.8% | at low | -85.8% | +2390.4% |
Context Therapeutics Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $259.00 K(+2390.4%) |
| Jun 2024 | - | $10.40 K(-20.0%) |
| Mar 2024 | - | $13.00 K(-16.1%) |
| Dec 2023 | $16.05 M(-57.6%) | $15.50 K(-14.4%) |
| Sep 2023 | - | $18.10 K(-65.7%) |
| Jun 2023 | - | $52.70 K(-34.5%) |
| Mar 2023 | - | $80.50 K(-28.3%) |
| Dec 2022 | $37.85 M | $112.30 K(-21.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $143.80 K(-27.0%) |
| Jun 2022 | - | $197.00 K(+12.3%) |
| Mar 2022 | - | $175.50 K(+248.2%) |
| Dec 2021 | $51.26 M(>+9900.0%) | $50.40 K(-97.2%) |
| Sep 2021 | - | $1.82 M(+28.5%) |
| Jun 2021 | - | $1.42 M(+144.2%) |
| Mar 2021 | - | $580.70 K(+245.7%) |
| Dec 2020 | $299.30 K(+24.9%) | $168.00 K |
| Dec 2019 | $239.60 K | - |
FAQ
- What is Context Therapeutics annual long term assets?
- What is the all time high annual non current assets for Context Therapeutics?
- What is Context Therapeutics annual non current assets year-on-year change?
- What is Context Therapeutics quarterly long term assets?
- What is the all time high quarterly non current assets for Context Therapeutics?
- What is Context Therapeutics quarterly non current assets year-on-year change?
What is Context Therapeutics annual long term assets?
The current annual non current assets of CNTX is $15.50 K
What is the all time high annual non current assets for Context Therapeutics?
Context Therapeutics all-time high annual long term assets is $168.00 K
What is Context Therapeutics annual non current assets year-on-year change?
Over the past year, CNTX annual long term assets has changed by -$96.80 K (-86.20%)
What is Context Therapeutics quarterly long term assets?
The current quarterly non current assets of CNTX is $259.00 K
What is the all time high quarterly non current assets for Context Therapeutics?
Context Therapeutics all-time high quarterly long term assets is $1.82 M
What is Context Therapeutics quarterly non current assets year-on-year change?
Over the past year, CNTX quarterly long term assets has changed by +$248.60 K (+2390.38%)